IP Verse

Stabilized Non-Protein Clostridial Toxin Compositions

PatentPatent Analysis

EP3436054

ALLERGAN
Application Number
EP17784058A
Filing Date
Sep 13, 2017
Status
Patent Maintained As Amended
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2442821B2
EP3509559B8
EP2877138B1

Biblio Summary

The patent EP3436054B2 was granted to Allergan on Jul 27, 2022 following the initial filing on Sep 13, 2017 under the application number EP17784058A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

IPSEN PHARMAMay 12, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents